227 related articles for article (PubMed ID: 14685705)
21. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
Zhang JH; Chen ZW; Wu Z
Can J Physiol Pharmacol; 2008 Mar; 86(3):131-8. PubMed ID: 18418440
[TBL] [Abstract][Full Text] [Related]
22. Myocardial protection by ischemic preconditioning and delta-opioid receptor activation in the isolated working rat heart.
Karck M; Tanaka S; Bolling SF; Simon A; Su TP; Oeltgen PR; Haverich A
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):986-92. PubMed ID: 11689805
[TBL] [Abstract][Full Text] [Related]
23. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator.
Inagaki K; Hahn HS; Dorn GW; Mochly-Rosen D
Circulation; 2003 Aug; 108(7):869-75. PubMed ID: 12860903
[TBL] [Abstract][Full Text] [Related]
24. The effects of isosteviol against myocardium injury induced by ischaemia-reperfusion in the isolated guinea pig heart.
Xu D; Zhang S; Foster DJ; Wang J
Clin Exp Pharmacol Physiol; 2007; 34(5-6):488-93. PubMed ID: 17439420
[TBL] [Abstract][Full Text] [Related]
25. Pre-ischemic administration of landiolol prevents ischemia-reperfusion injury in the rat heart.
Takahashi Y; Shibata T; Sasaki Y; Hirai H; Takemura S; Minamiyama Y; Sakaguchi M; Suehiro S
Osaka City Med J; 2007 Jun; 53(1):9-16. PubMed ID: 17867629
[TBL] [Abstract][Full Text] [Related]
26. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
[TBL] [Abstract][Full Text] [Related]
27. [Mechanism of cardioprotection against ischemia/reperfusion injury by valsartan: an experiment with isolated rat hearts].
Zhang YJ; Bai XJ; Qi ZM; Wang HX
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3350-3. PubMed ID: 16409843
[TBL] [Abstract][Full Text] [Related]
28. Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner.
Pantos C; Bescond-Jacquet A; Tzeis S; Paizis I; Mourouzis I; Moraitis P; Malliopoulou V; Politi ED; Karageorgiou H; Varonos D; Cokkinos DV
Basic Res Cardiol; 2005 Mar; 100(2):154-60. PubMed ID: 15616764
[TBL] [Abstract][Full Text] [Related]
29. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism.
Zhang KR; Liu HT; Zhang HF; Zhang QJ; Li QX; Yu QJ; Guo WY; Wang HC; Gao F
Apoptosis; 2007 Sep; 12(9):1579-88. PubMed ID: 17505785
[TBL] [Abstract][Full Text] [Related]
30. Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts.
Ramasamy R; Hwang YC; Liu Y; Son NH; Ma N; Parkinson J; Sciacca R; Albala A; Edwards N; Szabolcs MJ; Cannon PJ
Circulation; 2004 Apr; 109(13):1668-73. PubMed ID: 15051645
[TBL] [Abstract][Full Text] [Related]
31. Atractyloside and 5-hydroxydecanoate block the protective effect of puerarin in isolated rat heart.
Gao Q; Pan HY; Qiu S; Lu Y; Bruce IC; Luo JH; Xia Q
Life Sci; 2006 Jun; 79(3):217-24. PubMed ID: 16458326
[TBL] [Abstract][Full Text] [Related]
32. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
Sivarajah A; McDonald MC; Thiemermann C
Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
[TBL] [Abstract][Full Text] [Related]
33. 12-lipoxygenase in opioid-induced delayed cardioprotection: gene array, mass spectrometric, and pharmacological analyses.
Patel HH; Fryer RM; Gross ER; Bundey RA; Hsu AK; Isbell M; Eusebi LO; Jensen RV; Gullans SR; Insel PA; Nithipatikom K; Gross GJ
Circ Res; 2003 Apr; 92(6):676-82. PubMed ID: 12623876
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury.
Li D; Qu Y; Tao L; Liu H; Hu A; Gao F; Sharifi-Azad S; Grunwald Z; Ma XL; Sun JZ
J Surg Res; 2006 Mar; 131(1):64-72. PubMed ID: 16154595
[TBL] [Abstract][Full Text] [Related]
35. Myocardial protective effect of FR167653; a novel cytokine inhibitor in ischemic-reperfused rat heart.
Aleshin A; Sawa Y; Ono M; Funatsu T; Miyagawa S; Matsuda H
Eur J Cardiothorac Surg; 2004 Nov; 26(5):974-80. PubMed ID: 15519192
[TBL] [Abstract][Full Text] [Related]
36. Preservation of mitochondrial function during ischemia as a possible mechanism for cardioprotection of diltiazem against ischemia/reperfusion injury.
Takeo S; Tanonaka K; Iwai T; Motegi K; Hirota Y
Biochem Pharmacol; 2004 Feb; 67(3):565-74. PubMed ID: 15037208
[TBL] [Abstract][Full Text] [Related]
37. Sivelestat reduces myocardial ischemia and reperfusion injury in rat hearts even when administered after onset of myocardial ischemia.
Kambe M; Bessho R; Fujii M; Ochi M; Shimizu K
Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):629-34. PubMed ID: 19279053
[TBL] [Abstract][Full Text] [Related]
38. Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury.
Vessey DA; Kelley M; Li L; Huang Y; Zhou HZ; Zhu BQ; Karliner JS
Med Sci Monit; 2006 Oct; 12(10):BR318-24. PubMed ID: 17006394
[TBL] [Abstract][Full Text] [Related]
39. Hypertonic perfusion reduced myocardial injury during subsequent ischemia and reperfusion in normal and hypertensive rats.
Chen LB; Liu T; Wu JX; Chen XF; Wang L; Fan CL; Gao PJ; Higashino H; Lee WH; Yuan WJ; Chen H
Acta Pharmacol Sin; 2003 Nov; 24(11):1077-82. PubMed ID: 14627488
[TBL] [Abstract][Full Text] [Related]
40. [Effect of 17beta-estradiol on myocardial inducible NOS and endothelial NOS activities after ischemia-reperfusion in rat heart model].
Wang XD; Wang ZM; Jia DL; Yu P
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1789-91. PubMed ID: 17919391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
